Environment, lifestyle, and Parkinson's disease: Implications for prevention in the next decade
- PMID: 31091353
- DOI: 10.1002/mds.27720
Environment, lifestyle, and Parkinson's disease: Implications for prevention in the next decade
Abstract
There is evidence from observational studies for a role of a number of environmental exposures and lifestyle habits in modulating the risk for Parkinson's disease. Environmental and lifestyle associations, if causal, represent opportunities for Parkinson's disease prevention or disease modification at individual and population levels. In the past decade, additional evidence has been published that improves causal inference and/or enhances our understanding of the complexity of these associations. A number of gene-environment interactions have been elucidated, and our understanding of the roles of physical activity, pesticide and other chemical exposures, dietary habits, emotional stress, head injury, and smoking has been refined. In the next decade, better techniques will help us to close the gaps in our knowledge, including taking into account Parkinson's disease heterogeneity and gene and risk factor interactions in observational studies. To do this, larger datasets, global consortia, genomewide environment interaction studies, prospective studies throughout the lifespan, and improvements in the methodology of clinical trials of physical activity will be key. Despite the caveats of observational studies, a number of low-risk and potentially high-yield recommendations for lifestyle modification could be made to minimize the individual and societal burdens of Parkinson's disease, including dietary modifications, increasing physical activity, and head injury avoidance. Furthermore, a reduction in pesticide use could have a major impact on global health related to and beyond Parkinson's disease. Given the increasing prevalence of this disorder, formulating and promoting these recommendations should be a high priority. © 2019 International Parkinson and Movement Disorder Society.
Keywords: Parkinson's disease; environment; gene-environment interactions.
© 2019 International Parkinson and Movement Disorder Society.
Comment in
-
Reconciling etiological views on Parkinson's disease.Mov Disord. 2019 Nov;34(11):1750-1752. doi: 10.1002/mds.27875. Mov Disord. 2019. PMID: 31743512 No abstract available.
Similar articles
-
Genome-wide gene-environment interaction analysis of pesticide exposure and risk of Parkinson's disease.Parkinsonism Relat Disord. 2016 Nov;32:25-30. doi: 10.1016/j.parkreldis.2016.08.002. Epub 2016 Aug 3. Parkinsonism Relat Disord. 2016. PMID: 27545685 Free PMC article.
-
Parkinson's disease: evidence for environmental risk factors.Mov Disord. 2013 Jan;28(1):8-13. doi: 10.1002/mds.25150. Epub 2012 Oct 24. Mov Disord. 2013. PMID: 23097348 Review.
-
Gene-environment interactions in sporadic Parkinson's disease.J Neurochem. 2006 Jun;97(6):1740-55. doi: 10.1111/j.1471-4159.2006.03937.x. J Neurochem. 2006. PMID: 16805780 Review.
-
Environmental risk factors and Parkinson's disease: An umbrella review of meta-analyses.Parkinsonism Relat Disord. 2016 Feb;23:1-9. doi: 10.1016/j.parkreldis.2015.12.008. Epub 2015 Dec 17. Parkinsonism Relat Disord. 2016. PMID: 26739246
-
Epidemiologic approaches to the study of Parkinson's disease etiology.Epidemiology. 1999 May;10(3):327-36. Epidemiology. 1999. PMID: 10230846 Review.
Cited by
-
Oral Trehalose Intake Modulates the Microbiota-Gut-Brain Axis and Is Neuroprotective in a Synucleinopathy Mouse Model.Nutrients. 2024 Sep 30;16(19):3309. doi: 10.3390/nu16193309. Nutrients. 2024. PMID: 39408276 Free PMC article.
-
Role of HCN channels in the functions of basal ganglia and Parkinson's disease.Cell Mol Life Sci. 2024 Mar 13;81(1):135. doi: 10.1007/s00018-024-05163-w. Cell Mol Life Sci. 2024. PMID: 38478096 Free PMC article. Review.
-
Projections for prevalence of Parkinson's disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021.BMJ. 2025 Mar 5;388:e080952. doi: 10.1136/bmj-2024-080952. BMJ. 2025. PMID: 40044233 Free PMC article.
-
Personalized medication recommendations for Parkinson's disease patients using gated recurrent units and SHAP interpretability.Sci Rep. 2025 May 30;15(1):19074. doi: 10.1038/s41598-025-04217-8. Sci Rep. 2025. PMID: 40447777 Free PMC article.
-
The industrial solvent trichloroethylene induces LRRK2 kinase activity and dopaminergic neurodegeneration in a rat model of Parkinson's disease.Neurobiol Dis. 2021 Jun;153:105312. doi: 10.1016/j.nbd.2021.105312. Epub 2021 Feb 23. Neurobiol Dis. 2021. PMID: 33636387 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous